The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation

Abstract Cardiomyopathy is a frequent complication of propionic acidemia (PA). It is often fatal, and its occurrence is largely independent of classic metabolic treatment modalities. Liver transplantation (LT) is a treatment option for severe PA as the liver plays a vital role in metabolism of the p...

Full description

Bibliographic Details
Main Authors: Gerard T. Berry, Elizabeth D. Blume, Ann Wessel, Tajinder Singh, Leah Hecht, Deborah Marsden, Inderneel Sahai, Scott Elisofon, Michael Ferguson, Heung Bae Kim, David J. Harris, Didem Demirbas, Mohammed Almuqbil, William L. Nyhan
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:JIMD Reports
Subjects:
Online Access:https://doi.org/10.1002/jmd2.12119
_version_ 1818259936041238528
author Gerard T. Berry
Elizabeth D. Blume
Ann Wessel
Tajinder Singh
Leah Hecht
Deborah Marsden
Inderneel Sahai
Scott Elisofon
Michael Ferguson
Heung Bae Kim
David J. Harris
Didem Demirbas
Mohammed Almuqbil
William L. Nyhan
author_facet Gerard T. Berry
Elizabeth D. Blume
Ann Wessel
Tajinder Singh
Leah Hecht
Deborah Marsden
Inderneel Sahai
Scott Elisofon
Michael Ferguson
Heung Bae Kim
David J. Harris
Didem Demirbas
Mohammed Almuqbil
William L. Nyhan
author_sort Gerard T. Berry
collection DOAJ
description Abstract Cardiomyopathy is a frequent complication of propionic acidemia (PA). It is often fatal, and its occurrence is largely independent of classic metabolic treatment modalities. Liver transplantation (LT) is a treatment option for severe PA as the liver plays a vital role in metabolism of the precursors that accumulate in patients with PA. LT in PA is now considered to be a long‐lasting and valid treatment to prevent cardiac disease. The subject of this report had severe cardiomyopathy that largely disappeared prior to undergoing a LT. Three years following the transplant, there was recurrence of cardiomyopathy following a surgery that was complicated with a postoperative aspiration pneumonia. On his last hospital admission, he was presented with pulmonary edema and heart failure. He continued with episodes of intractable hypotension, despite maximum inotropic and diuretic support. He died following redirection of care. We conclude that lethal cardiomyopathy may develop several years after successful LT in patients with PA.
first_indexed 2024-12-12T18:23:21Z
format Article
id doaj.art-ab2641ca9a6d489a88e3074f2d6a20bb
institution Directory Open Access Journal
issn 2192-8312
language English
last_indexed 2024-12-12T18:23:21Z
publishDate 2020-07-01
publisher Wiley
record_format Article
series JIMD Reports
spelling doaj.art-ab2641ca9a6d489a88e3074f2d6a20bb2022-12-22T00:16:05ZengWileyJIMD Reports2192-83122020-07-015413810.1002/jmd2.12119The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantationGerard T. Berry0Elizabeth D. Blume1Ann Wessel2Tajinder Singh3Leah Hecht4Deborah Marsden5Inderneel Sahai6Scott Elisofon7Michael Ferguson8Heung Bae Kim9David J. Harris10Didem Demirbas11Mohammed Almuqbil12William L. Nyhan13Division of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADepartment of Cardiology, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADepartment of Cardiology, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USAPediatrics‐Genetics Department, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USADivision of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Nephrology, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADepartment of Surgery, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADivision of Genetics and Genomics, The Manton Center for Orphan Disease Research, Boston Children's Hospital Harvard Medical School Boston Massachusetts USADepartment of Pediatrics University of California San Diego La Jolla California USAAbstract Cardiomyopathy is a frequent complication of propionic acidemia (PA). It is often fatal, and its occurrence is largely independent of classic metabolic treatment modalities. Liver transplantation (LT) is a treatment option for severe PA as the liver plays a vital role in metabolism of the precursors that accumulate in patients with PA. LT in PA is now considered to be a long‐lasting and valid treatment to prevent cardiac disease. The subject of this report had severe cardiomyopathy that largely disappeared prior to undergoing a LT. Three years following the transplant, there was recurrence of cardiomyopathy following a surgery that was complicated with a postoperative aspiration pneumonia. On his last hospital admission, he was presented with pulmonary edema and heart failure. He continued with episodes of intractable hypotension, despite maximum inotropic and diuretic support. He died following redirection of care. We conclude that lethal cardiomyopathy may develop several years after successful LT in patients with PA.https://doi.org/10.1002/jmd2.12119cardiomyopathyheart failureheart transplantationliver transplantationorganic acid disorderpropionic acidemia
spellingShingle Gerard T. Berry
Elizabeth D. Blume
Ann Wessel
Tajinder Singh
Leah Hecht
Deborah Marsden
Inderneel Sahai
Scott Elisofon
Michael Ferguson
Heung Bae Kim
David J. Harris
Didem Demirbas
Mohammed Almuqbil
William L. Nyhan
The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
JIMD Reports
cardiomyopathy
heart failure
heart transplantation
liver transplantation
organic acid disorder
propionic acidemia
title The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
title_full The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
title_fullStr The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
title_full_unstemmed The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
title_short The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
title_sort re occurrence of cardiomyopathy in propionic acidemia after liver transplantation
topic cardiomyopathy
heart failure
heart transplantation
liver transplantation
organic acid disorder
propionic acidemia
url https://doi.org/10.1002/jmd2.12119
work_keys_str_mv AT gerardtberry thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT elizabethdblume thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT annwessel thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT tajindersingh thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT leahhecht thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT deborahmarsden thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT inderneelsahai thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT scottelisofon thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT michaelferguson thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT heungbaekim thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT davidjharris thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT didemdemirbas thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT mohammedalmuqbil thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT williamlnyhan thereoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT gerardtberry reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT elizabethdblume reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT annwessel reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT tajindersingh reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT leahhecht reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT deborahmarsden reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT inderneelsahai reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT scottelisofon reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT michaelferguson reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT heungbaekim reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT davidjharris reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT didemdemirbas reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT mohammedalmuqbil reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation
AT williamlnyhan reoccurrenceofcardiomyopathyinpropionicacidemiaafterlivertransplantation